The global Enzymatic Wound Debridement Market size is expected to reach USD 1.10 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a 5.8% CAGR during the forecast period Introduction of technologically advanced products and rise in incidence of chronic diseases are some of the key factors aiding growth.
Various initiatives are being undertaken by researchers and key players are developing technologically advanced products owing to rising demand for enzymatic wound debridement products globally, which is anticipated to boost market growth. Until now, collagenase-based enzymatic wound debridement products have been majorly used for treatment of chronic & acute wounds and papain-based products have been predominantly used for treatment of chronic wounds. Since awareness about the use of such products is increasing, several technologically advanced products are being introduced in the market. For instance, NexoBrid (NXB), previously referred to as Debriding Gel Dressing (DGD)—which is derived from pineapple Bromelain group of enzymes-was introduced in 2017. NXB is an enzymatic wound debriding drug that can be effectively used in treating deep burn wounds.
The product recently received approval and market players are undertaking initiatives to launch this product under their wound care product portfolio. For instance, in May 2019, Vericel Corporation entered into a supply agreement and exclusive license with MediWound Ltd. with an aim to commercialize the product in North America. The product also received approval in European Union, the U.S., and other international markets. Therefore, such initiatives are anticipated to positively impact growth over the forecast period.
Request a Sample Copy of the Global Enzymatic Wound Debridement Research Report @ https://www.grandviewresearch.com/industry-analysis/enzymatic-wound-debridement-market/request/rs1
Further key findings from the report suggest:
- In terms of revenue, acute wounds segment held the largest share in 2018 owing to rising trauma cases
- Homecare segment is expected to witness fastest growth rate over the forecast period owing to increasing geriatric population suffering from chronic wounds, who prefer homecare over hospital stay
- Collagenase product segment held the largest share in 2018 due to rising incidence of chronic wounds
- Asia Pacific is expected to witness fastest growth over the forecast period owing to rising number diabetic patients in this region
- Some prominent players operating in enzymatic wound debridement market are Smith & Nephew, Mölnlycke Health Care, ConvaTec, and B. Braun.
Have Any Query? Ask Our Experts@ https://www.grandviewresearch.com/inquiry/6256/ibb
Grand View Research has segmented the enzymatic wound debridement market report on the basis of product, type, end use, and region:
Enzymatic Wound Debridement Type Outlook (Revenue, USD Million, 2015 – 2026)
- Chronic Wounds
- Diabetic Foot Ulcers
- Pressure Ulcers
- Venous Leg Ulcers
- Acute Wounds
Enzymatic Wound Debridement Product Outlook (Revenue, USD Million, 2015 – 2026)
- Collagenase Product
- Papain Product
Enzymatic Wound Debridement End-use Outlook (Revenue, USD Million, 2015 – 2026)
Enzymatic Wound Debridement Regional Outlook (Revenue, USD Million, 2015 – 2026)
- North America
- Asia Pacific
- Latin America
- South Africa
- Saudi Arabia
Browse Related Reports @
Traditional Wound Management Market – https://www.grandviewresearch.com/industry-analysis/traditional-wound-management-market
Wound Debridement Market – https://www.grandviewresearch.com/industry-analysis/wound-debridement-market
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
Country: United States